|
 |
 |
Nventa Biopharmaceuticals, Corp.
(NVN.TO, TSX)
12.17.07
A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV).
|
|
 |
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
12.03.07
A New Tool for Rescuing Patients
Who’s Livers Are Failing.
|
|
 |
|
Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.19.07
Reversing the Trend by Energizing Optix®’s Commercialization
Strategy with a Higher Margin Opportunity and Sales Leadership.
|
|
 |
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
11.13.07
Injecting Confidence to the Viprinex™
Mission by a Successful $60m Offering; Mountains Do Move.
|
|
 |
|
StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC: BB)
11.06.07
FDA Approves CLIA Waiver for
StatSure’s Patented Barrel Technology for Rapid HIV Testing.
|
|
|
|
StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC: BB)
10.25.07
Opportunity Unfolds for Investors Seeking to Participate In Proprietary Point-of-Care Product Firm.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
09.19.07
The Secret of Success is Constancy of Purpose: VIPRINEX™ Could Restore Stroke
Patients to Fuller Lives and They Will Be the Real Miracle of NTII's Achievement.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: OTC.BB)
09.13.07
Enhancing the Survival of Patients with Life Threatening Episodes of Liver Failure.
|
|
|
|
Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.20.07
Mapping the Road Ahead With an Execution Agenda.
|
|
|
|
Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.16.07
The Future and the Products are Now in Their Hands.
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
05.15.07
Clinical Trials Don't Come Cheap Especially When there are Multiple Sites in the US and Internationally.
|
|
 |
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
05.08.07
"Hemangioblast" Precursor Cells Produced From Human Embryonic Stem Cells Show Remarkable Ability to Repair Vascular Damage in Animals.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: ABOS: OTC: BB)
04.26.07
SEPET™ Advances Facilitate a Financing with New Institutional Investors.
|
|
|
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
04.18.07
Translating Stem Cell Development into Therapeutic Outcomes.
|
|
|
|
Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.27.07
A CE Marking for the EU and an Unconditional Health Canada Medical Device License to Commercialize SoftScan®, a Financing and an Extension of its Agreement with GE Healthcare for eXplore Optix™
|
|
|
|
Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.13.07
Royalties Pour In, Momentum Rebuilds, Losses Decrease and Encouraging Viprinex™ Clinical Trials Advance Supported by the Role of Fibrinogen in Influencing Stroke Outcome.
|
|
|
|
Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
01.29.07
The Road to Commercial Development of New Therapies from Stem Cells.
|
|
|
|
Arbios Systems, Inc.
(NASDAQ: ABOS: OTC: BB)
01.17.07
Developing Multiple Products to Meet the Unmet Medical Needs of Patients in Liver Crisis.
|
